Background: Primary cardiac adipose tumors are rare. There are two distinct
| INTRODUCTION
Primary cardiac adipose tumors are rare but benign lesions. These lesions comprise two distinct pathologically defined entities: lipoma and lipomatous hypertrophy of the interatrial septum (LHIS). Lipoma refers to a homogenous encapsulated collection of mature adipocytes with intervening fine fibrous tissue and minimal to no cellular atypia. 1 LHIS is non-encapsulated adipocyte hyperplasia within normal cardiac tissue with islands or strands of non-lipomatous cells, usually cardiomyocytes, within the mass.
1,2 LHIS is most commonly found in the interatrial septum.
Autopsy series show an incidence of less than 0.1% for lipomas and 2-8% for LHIS 3, 4 in the general population. Among heart tumors, lipomas have been reported to represent 2-8% of all surgically treated tumors. 5, 6 While most are asymptomatic, a wide range of cardiovascular adverse events, including death, have been described. [7] [8] [9] [10] [11] [12] [13] [14] Most commonly, symptoms are caused by native structure compression or impingement of adequate blood flow. These lesions occur in all chambers of the heart, with the interatrial septum being the most reported site (39%), followed by the right atrium (RA) (18%), left ventricle (LV) (12%), and right ventricle (5%). Pericardial lesions have also been described, and represented 13% of reported cases. 15 The clinical differentiation of the two pathologic entities is not possible in most patients. [11] [12] Surgical resection is recommended for most patients unless a cardiac lipoma is diagnosed incidentally, without associated symptoms, life-threatening arrhythmias, or signs of myocardial ischemia. 16 We present a single-center experience with surgical treatment of six primary cardiac adipose tumors, encompassing both lipomas and LHIS, and describe differences between the two pathologic types and demonstrate that "LHIS" may also occur in non-traditional sites.
| METHODS
This study was approved by our Institutional Research Ethics Board with a waiver of consent. Between January 1990 and July 2016, there were 254 adult patients who underwent surgical treatment of a primary cardiac tumor in the Toronto General Hospital. Six of these cases were primary cardiac adipose tumors (2%). In two of these cases (33%), the diagnosis was primarily established intraoperatively.
Median sternotomy and cardiopulmonary bypass were used in all cases. A bovine pericardial patch was used for reconstruction of any residual defects. A predischarge transthoracic echocardiogram confirmed absence of residual masses and masses and documented cardiac function in all patients. All patients had a scheduled follow-up visit with their surgeon 3 months following surgery.
Continuous variables are presented as mean ± standard deviation.
Categorical variables are presented as proportions.
| RESULTS
Preoperative characteristics of the six patients with primary cardiac adipose tumors are detailed in Table 1 . Two patients (33%) were asymptomatic; however, one of the symptomatic patients, who was undergoing a primary mitral valve operation, had symptoms likely referable to mitral valve regurgitation. In 5/6 cases (83%), cardiac function was preserved. Primary cardiac adipose tumor was identified preoperatively in 4/6 (67%) patients. All patients presented in New
York Heart Association functional Class ≤2 prior to surgery.
Operative interventions performed are outlined in Table 2 . A bovine pericardial patch was used for reconstruction in 3/6 cases (50%), all in the RA. The lesion along the ascending aorta (lipoma) and the subepicardial mass at the surface of the interatrial groove (LHIS)
were resected primarily. The other patient, with a LV LHIS (Figure 1 ), had a resection with primary LV repair.
Individual demographic and perioperative information is presented on Table 3 coronary artery branch and the coronary sinus. The lesion was resected without damage to any of these structures and the LV was repaired using a mattress-type interrupted closure with monofilament suture and subsequent running suture overlying the initial layer, for hemostasis.
The lesion was diagnosed as a LHIS (Figures 1 and 2) . Lastly, the sixth case was a 71-year-old female who presented with a seizure. Upon investigation, a brain CT and magnetic resonance imaging (MRI) showed cerebral edema and a right temporal meningioma, which was excised. In-hospital and 3-month outcomes are presented in Table 4 
| DISCUSSION
Primary cardiac adipose tumors occurring in the heart are benign tumors consisting of either encapsulated or non-encapsulated mature adipocytes, and can occur in all areas of the heart. Even within the RA, they may occur distant from the interatrial septum or atrioventricular groove, or extend into the superior vena cava. 17 These lesions typically grow to a large size before presentation. As with all cardiac tumors, symptoms are non-specific, including palpitations, which may, as in our case, include ventricular tachycardia. The initial diagnosis is usually established by echocardiography. CT scan and cardiac MRI are usually subsequently performed and may help elucidate the nature of the tissue (ie, lipomatous tissue) and extent of infiltration. 16 Sometimes, however, AA, ascending aorta; AAR, ascending aortic replacement; CABG, coronary artery bypass; CT, computed tomography; IVC, inferior vena cava; LHIS, lipomatous hypertrophy of interatrial septum; LV, left ventricle; MR, mitral regurgitation; MRI, magnetic resonance imaging; MVR, mitral valve replacement; PPM, permanent pacemaker; RA, right atrium; RBC, red blood cell; RCA, right coronary artery; RUL, right upper lobe; SVC, superior vena cava; SVG, saphenous venous graft; Sx, surgery.
FIGURE 2
Endocardial protrusion of more than one lipomatous protuberance into the left ventricular cavity. These were not appreciated on preoperative imaging and could conceivably lead to embolization reporting three cases. 24 Two large Institutional reports presented outcomes of all primary cardiac tumors. These studies included seven and 12 adipose tumors, respectively. 25, 26 No specific discussion or analysis of the adipose tumors was undertaken. Given the confusion between LHIS and lipoma in the surgical community, the actual number of each pathologic entity is unknown in most reports.
The clinical manifestations of primary cardiac adipose tumors are usually not related to embolization, [7] [8] [9] [10] [11] [12] [13] [14] although there have been a small number of case reports describing embolic events in these patients. 27, 28 Our patient with an LV mass had intra-cardiac extensions of LHIS, but without documented emboli. The only neurological event seen in our patient was related to the brain tumor (meningioma), and not related to the cardiac tumor.
As with most benign tumors, growth can be very slow, with many being large at the time of presentation and diagnosis. At the time of presentation, our experience revealed an average tumor diameter of 63 mm ( Our experience supports the use of an interdisciplinary preoperative evaluation of all cardiac tumors, with cardiology and radiological investigation and consultation. Postoperative management is also multidisciplinary. This team approach, which should be adopted by all institutions, has allowed us to resect a large variety of tumors and has provided optimal diagnosis, treatment, and postresection care. A limitation of this study is the lack of long-term followup for these patients beyond the first 3 months following surgery.
Although these tumors are benign lesions and unlikely to metastasize, it is conceivable that an inadequate initial resection of the fatty tumor may lead to a local recurrence. Therefore, the follow-up for these patients should include serial imaging studies. In-hospital mortality 0 (0%) AMI, acute myocardial infarction; Hb, hemoglobin; ICU, intensive care unit; RBC, red blood cell.
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